Policy

Nordic States foster Bioeconomy
Enlarge image

BusinessFinland

Nordic States foster Bioeconomy

13.04.2012 - Finland is the last Nordic country which has not yet decided to start a nationwide bioeconomy programme. Calls for such an strategy are becoming louder.

Helsinki – Denmark has already implemented a national bioeconomy strategy, investing €1.8bn by 2015. At the end of March, Norway and Sweden announced at the "Bioeconomy in Action" conference that they would also start countrywide efforts. Norway intends to spend as much as €300m in total. Demands for Finland not to fall behind are becoming more pressing. Erkki KM Leppävuori, President and CEO of the VTT Technical Research Centre of Finland, said during a conference on April 12, "Finland should create a national bioeconomy strategy as soon as possible". According to Leppävuori, bioeconomy has all the prerequisites for creating a radical increase in the value of exports and for developing into a new pillar of support for wellbeing in Finland. "This will require the making of choices, the taking of risks, and the development and marketing of bioeconomy-based technologies", he added. Finland’s forest industry especially might profit from such a move. According to expert assessment, by 2020 new technological solutions and diversification could raise Finland's production by €6bn (equal to an increase of 22% compared to the 2010 level). Current operations could be expanded into the production of composites, biofuels and biochemicals, and into service businesses. Leppävuori already has a suggestion for facilitating the necessary changes, "The renewal of Finland’s business sector can be expedited by forming a voluntary partnership network – the Finnish Institute of Technology and Innovation (FIT). Research programs in the network could be opened up to each other and large-scale multidisciplinary projects initiated in applied research." Leppävuori added, "This is also a question of effective utilization of Finland’s limited research resources."

http://www.european-biotechnology-news.com/news/news/2012-02/nordic-states-foster-bioeconomy.html

FinancingFrance

21.10.2014 Yet another European company is looking for money on the US stock exchange – French DBV Technologies SA is all set up for its secondary listing on NASDAQ. The French biotech company hopes to rake in US$98m for its peanut allergy patches.

FinancingDenmark

18.10.2014 After raising US$220.5m (€172m) with its IPO, fast Forward Pharma’s lucky streak hits an obstacle on the road to success with shares falling 17% on its first day of trading.

M&AUKItaly

17.10.2014 Abandoned at the altar: Abbvie has dropped plans to acquire UK’s Shire following new US tax rules. This puts a stop to one of the biggest pharma mergers planned this year.

FinancingUKBelgium

15.10.2014 Bicycle Therapeutics wins €25m backing by major pharma venture capitalists for the development of a new class of oncology drugs.

FinancingGermanySwitzerlandNetherlands

13.10.2014 Biotechnology IPOs are back in fashion – German Probiodrug AG wants to raise €32m with its IPO, whilst Swiss Molecular Partners AG hopes the launch of its IPO will gain a revenue of €145m.

BusinessIreland

10.10.2014 Actavis has announced plans to merge with American pharma company Durata - a move that will strengthen their infectious diseases portfolio.

RegulationEU

07.10.2014 In an unprecedented move, the European Medicines Agency has approved a system allowing the future analysis of clinical trial data.

FinanceNetherlandsEU

06.10.2014 Another fund from the Netherlands has raised €92m in its first close and will invest the money in companies developing innovative therapeutics, medical devices and diagnostics.

FinanceNetherlandsUKSwitzerland

03.10.2014 Dutch venture capitalist LSP has achieved its monetary milestone by raising €80m for its fifth fund - with a goal of €150m.

PoliticsEULithuaniaPoland

02.10.2014 New EU commission chief Jean-Claude Juncker is on the defensive after members of Parliament and NGOs criticised his reorganisation of the health technology units.

Events

All Events

Current issue

All issues

Product of the week

Products

Stock list

All quotes

TOP

  • MEDIGENE3.85 EUR8.15%
  • EVOTEC2.87 EUR7.49%
  • 4SC0.84 EUR5.00%

FLOP

  • CYTOS0.15 CHF-6.25%
  • EPIGENOMICS3.42 EUR-0.87%
  • STRATEC BIOMEDICAL37.50 EUR-0.87%

TOP

  • BIOFRONTERA2.91 EUR29.9%
  • ADDEX3.44 CHF5.8%
  • HBM86.00 CHF3.7%

FLOP

  • PAION2.19 EUR-32.6%
  • CYTOS0.15 CHF-28.6%
  • 4SC0.84 EUR-26.3%

TOP

  • SANTHERA82.00 CHF2269.9%
  • CO.DON2.82 EUR209.9%
  • PAION2.19 EUR154.7%

FLOP

  • CYTOS0.15 CHF-96.2%
  • 4SC0.84 EUR-51.7%
  • THERAMETRICS0.07 CHF-46.2%

No liability assumed, Date: 21.10.2014